Strainprint, which has focused on medical marijuana users but works just as well for recreational users, launched the day before legalization to take advantage of the attention pot would garner.
Enterprise-wide license to Strainprint Analytics, Clinic Edition, will provide unparalleled medical cannabis treatment guidance.
Have a listen to our Co-Founder & Chief Creative Officer, Stephanie Karasick as she interviews alongside Dr. Danial Schecter on the Alternative Food Network podcast on the Health Effects of Cannabis.
Michelle Arbus joined Business of Cannabis to talk about how the data that she will be presenting identifies trends among older cannabis users and what that means for medical cannabis patients.
CEO’s Journey with Cannabis Helps Community “Use Cannabis Better”
Strainprint Featured In The Green Market Report – Big Data Opens A New Path for Cannabis Patients Strainprint is leading the way in the cannabis industry with its rich and robust medical patient data and sophisticated Business Intelligence solutions. With a vision to advance the scientific understanding of cannabis and its legitimization as a therapy […]
Anxiety And Stress Scientifically Proven To Be Reduced By Cannabis
On June 13th, Jessica Moran, Strainprint Director of Marketing & Communications appeared on the Humble & Fred Radio show where she talked about Strainprint’s O’Cannabiz sponsorship, and the use of medical cannabis as a viable therapeutic option.
On June 7-9th Strainprint participated in O’Cannabiz as a platinum sponsor. The weekend was filled with insightful panels, productive industry discussions, and invaluable networking! Have a look at our round-up from the action-packed weekend below! We look foward to next year!